Quick Takeaways
- ADAR1 Capital Management, LLC filed SCHEDULE 13G for Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (OVID).
- Disclosed ownership: 6.9%.
- Date of event: 31 Dec 2025.
ADAR1 Capital Management, LLC - 31 Dec 2025 SCHEDULE 13G Report for Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (OVID)
- Filing Manager
- ADAR1 Capital Management, LLC
- Reporting Manager
- ADAR1 Capital Management, LLC
- Symbol
- OVID
- Shares outstanding
- 134,553,130 shares
- Disclosed Ownership
- 9,284,166 shares
- Ownership
- 6.9%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 20:17:42 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ADAR1 Capital Management, LLC disclosed 6.9% ownership in Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (OVID) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 20:17.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 6.9% | 9,284,166 | 0 | 9,284,166 | /s/ Daniel Schneeberger | Daniel Schneeberger, Manager | |
| ADAR1 Capital Management GP, LLC | 6.9% | 9,284,166 | 0 | 9,284,166 | /s/ Daniel Schneeberger | Daniel Schneeberger, Manager | |
| Daniel Schneeberger | 6.9% | 9,284,166 | 0 | 9,284,166 | /s/ Daniel Schneeberger | Daniel Schneeberger, in his individual capacity |